On Oct 20, Sequenta, Inc., announced an equity investment by Celgene Corporation (NASDAQ:CELG) and other strategic investors. This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT™ minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT™ platform. Celgene Corporation (NASDAQ:CELG) belongs to Healthcare sector. Its net profit margin is 20.80% and weekly performance is 9.49%. On last trading day company shares ended up $94.76. Celgene Corporation (NASDAQ:CELG) distance from 50-day simple moving average (SMA50) is 2.45%.

On Oct 08, The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Bankrate, Inc. (NYSE:RATE) between March 1, 2013 and September 15, 2014, inclusive (the “Class Period”). Bankrate, Inc. (NYSE:RATE) shares moved down -4.84% in last trading session and ended the day at $9.83. RATE Gross Margin is 66.70% and its return on assets is -1.20%. Bankrate, Inc. (NYSE:RATE) quarterly performance is -42.88%.

On Oct. 10 China Ming Yang Wind Power Group Limited (NYSE:MY) announced the appointment of Mr. Jinfa Wang as a member of the board of directors. He will succeed Mr. Xueyong Zhao who has served on the board of directors since April 2013. Mr. Xueyong Zhao has resigned as a member of the Company’s board of directors for personal reasons. Mr. Zhao has also at the same time resigned as the president of the Company. All committee and management changes are with immediate effect. On 22 October, China Ming Yang Wind Power Group Limited (NYSE:MY) shares moved down -1.20% and was closed at $2.46. MY EPS growth in last 5 year was 3.70%. China Ming Yang Wind Power Group Limited (NYSE:MY) year to date (YTD) performance is 0.41%.

On Oct 14, Gilead Sciences Inc. (NASDAQ:GILD) posted modest gains at the open Tuesday, but has spiked sharply to the downside in the last few minutes on increased volume. The stock is now down 3.18 at $98.26.Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 42.80% and weekly performance is 10.33%. On last trading day company shares ended up $106.09. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is 3.02%.

AxoGen, Inc. (NASDAQ:AXGN) currently has a Zacks Rank #3 (Hold). AxoGen, Inc. (NASDAQ:AXGN) shares moved down -6.98% in last trading session and ended the day at $2.40. AXGN Gross Margin is 78.90% and its return on assets is -59.70%. AxoGen, Inc. (NASDAQ:AXGN) quarterly performance is -2.04%.